These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6779250)

  • 21. Factor VIII-hydrolyzing IgG in acquired and congenital hemophilia.
    Wootla B; Mahendra A; Dimitrov JD; Friboulet A; Borel-Derlon A; Rao DN; Uda T; Borg JY; Bayry J; Kaveri SV; Lacroix-Desmazes S
    FEBS Lett; 2009 Aug; 583(15):2565-72. PubMed ID: 19595998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extracorporeal protein A-sepharose and specific affinity chromatography for removal of antibodies.
    Nilsson IM; Sundqvist SB; Freiburghaus C
    Prog Clin Biol Res; 1984; 150():225-41. PubMed ID: 6431430
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hemophilia A with inhibitor].
    Takahashi I
    Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):498-501. PubMed ID: 9833554
    [No Abstract]   [Full Text] [Related]  

  • 24. Idiotypic regulation of anti-factor VIII antibodies.
    Kazatchkine MD; Lacroix-Desmazes S; Moreau A; Kaveri SV
    Haematologica; 2000 Oct; 85(10 Suppl):97-9. PubMed ID: 11187885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Factor VIII inhibitors--their characteristics and clinical significance].
    Dmoszyńska A; Kniaź M; Sokołowska B
    Pol Arch Med Wewn; 1987 Dec; 78(6):333-40. PubMed ID: 3152083
    [No Abstract]   [Full Text] [Related]  

  • 26. The optimal treatment for haemophiliacs who have developed factor VIII or -IX antibodies.
    Engelfriet CP; Reesink HW; Mannucci PM; Gringeri A; Ingerslev J; Brettler DB; Mauser-Bunschoten EP; Negrier C; Berntorp E; Smith OP; Shapiro AD
    Vox Sang; 2000; 78(4):256-61. PubMed ID: 10970234
    [No Abstract]   [Full Text] [Related]  

  • 27. Factor VIII inhibitory antibody in a patient with combined factor V/factor VIII deficiency.
    Buckner TW; Nielsen BI; Key NS; Ma A
    Haemophilia; 2015 Jan; 21(1):e77-80. PubMed ID: 25472918
    [No Abstract]   [Full Text] [Related]  

  • 28. Acquired hemophilia and its treatment.
    Sultan Y
    Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S15-8. PubMed ID: 9351531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired cell-mediated immunity in hemophilia: suppression of natural killer activity by factor VIII.
    Ablin RJ; Bartkus JM
    J Lab Clin Med; 1986 Apr; 107(4):396-7. PubMed ID: 3083030
    [No Abstract]   [Full Text] [Related]  

  • 30. Von Willebrand factor-specific antibodies developing upon treatment of FVIII-deficient mice with different FVIII preparations.
    Kallas A; Kuuse S; Maimets T; Pooga M
    Acta Haematol; 2008; 119(4):244-7. PubMed ID: 18594135
    [No Abstract]   [Full Text] [Related]  

  • 31. Serial plasmapheresis in a haemophiliac with antibodies to FVIII.
    Cobcroft R; Tamagnini G; Dormandy KM
    J Clin Pathol; 1977 Aug; 30(8):763-5. PubMed ID: 599190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitor development in a multitransfused patient with severe haemophilia A.
    van den Berg HM; Roosendaal G; Voorberg J; Mauser-Bunschoten EP
    Thromb Haemost; 1999 Jul; 82(1):151-2. PubMed ID: 10456472
    [No Abstract]   [Full Text] [Related]  

  • 33. [Incidence of the appearance of factor VIII inhibitor in patients with hemophilia A at the Hemophilia Center of the Clinical Hospital Center in Zagreb].
    Ficović P; Tiefenbach A; Brkljacić V; Grgić Z
    Lijec Vjesn; 1983 Oct; 105(10):410-1. PubMed ID: 6418997
    [No Abstract]   [Full Text] [Related]  

  • 34. Control of life-threatening bleeding by combined plasmapheresis and immunosuppressive treatment in a haemophiliac with inhibitors.
    Révész T; Mátyus J; Goldschmidt B; Harsanyi V
    Arch Dis Child; 1980 Aug; 55(8):641-3. PubMed ID: 6776907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitors to factor VIII:C in nonhemophiliacs.
    Milica CD; Gradimir JM; Nada S; Radoje CB
    Am J Hematol; 1996 May; 52(1):61. PubMed ID: 8638615
    [No Abstract]   [Full Text] [Related]  

  • 36. Management of a lacerated frenum and lip in a child with severe hemophilia and an inhibitor: report of case.
    Powell D
    ASDC J Dent Child; 1976; 43(4):272-5. PubMed ID: 783228
    [No Abstract]   [Full Text] [Related]  

  • 37. International workshop on immune tolerance induction: consensus recommendations.
    DiMichele DM; Hoots WK; Pipe SW; Rivard GE; Santagostino E
    Haemophilia; 2007 Jul; 13 Suppl 1():1-22. PubMed ID: 17593277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Acquired hemophilia: current status in Japan and immuno-biochemical features of autoantibodies to factor VIII].
    Tanaka I; Shima N
    Rinsho Ketsueki; 2005 Feb; 46(2):91-8. PubMed ID: 16447701
    [No Abstract]   [Full Text] [Related]  

  • 39. Combinatorial peptides directed to inhibitory antibodies against human blood clotting factor VIII.
    Kopecky EM; Greinstetter S; Pabinger I; Buchacher A; Römisch J; Jungbauer A
    Thromb Haemost; 2005 Nov; 94(5):933-41. PubMed ID: 16363233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acquired hemophilia A: a concise review.
    Franchini M; Gandini G; Di Paolantonio T; Mariani G
    Am J Hematol; 2005 Sep; 80(1):55-63. PubMed ID: 16138334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.